HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-FEB-13 4J71 TITLE CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA, SERINE/THREONINE-PROTEIN KINASE GSK3B; COMPND 5 EC: 2.7.11.26, 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: BD BACULOGOLD PACG2T KEYWDS STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS KEYWDS 2 RESEARCH CONSORTIUM, NYSGRC, KINASE, PHOSPHORYLATION, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.ZHAN,Y.WANG,J.WACH,P.SHEEHAN,C.ZHONG,R.HARRIS,Y.PATSKOVSKY, AUTHOR 2 J.BISHOP,S.HAGGARTY,A.RAMEK,K.BERRY,C.O'HERIN,A.N.KOEHLER,A.W.HUNG, AUTHOR 3 D.W.YOUNG,S.C.ALMO,NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM AUTHOR 4 (NYSGRC) REVDAT 5 06-DEC-23 4J71 1 REMARK REVDAT 4 20-SEP-23 4J71 1 REMARK SEQADV REVDAT 3 17-JUL-19 4J71 1 REMARK LINK REVDAT 2 15-NOV-17 4J71 1 REMARK REVDAT 1 20-MAR-13 4J71 0 JRNL AUTH Y.WANG,J.WACH,P.SHEEHAN,C.ZHONG,C.ZHAN,R.HARRIS,S.C.ALMO, JRNL AUTH 2 J.BISHOP,S.HAGGARTY,A.RAMEK,K.BERRY,C.O'HERIN,A.N.KOEHLER, JRNL AUTH 3 A.W.HUNG,D.W.YOUNG JRNL TITL FRAGMENT-BASED APPROACH USING DIVERSITY-ORIENTED SYNTHESIS JRNL TITL 2 YIELDS A GSK3B INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 45698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1408 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3014 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 103 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5538 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -19.50000 REMARK 3 B22 (A**2) : 14.89000 REMARK 3 B33 (A**2) : 4.61000 REMARK 3 B12 (A**2) : 2.31000 REMARK 3 B13 (A**2) : -4.33000 REMARK 3 B23 (A**2) : 7.09000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.050 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.042 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.937 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; 0.003 ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; 0.698 ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; 0.045 ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; 0.001 ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4J71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077676. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000, DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45699 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.68700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1GNG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG-3350, 0.2M NA FORMATE, PH 7.2, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 PRO A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 SER A 35 REMARK 465 ILE A 384 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 PRO B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 SER B 35 REMARK 465 ILE B 384 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 36 CG CD CE NZ REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 LYS A 122 CG CD CE NZ REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 ASP A 124 CG OD1 OD2 REMARK 470 LYS B 36 CG CD CE NZ REMARK 470 ARG B 92 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 121 CG CD OE1 OE2 REMARK 470 LYS B 122 CG CD CE NZ REMARK 470 LYS B 123 CG CD CE NZ REMARK 470 ASP B 124 CG OD1 OD2 REMARK 470 ARG B 308 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 91 -19.67 -42.31 REMARK 500 GLU A 121 -91.47 -102.83 REMARK 500 ASP A 181 38.70 -146.08 REMARK 500 ASP A 200 80.22 60.63 REMARK 500 CYS A 218 151.25 76.45 REMARK 500 ASP A 233 64.35 -109.34 REMARK 500 SER A 236 6.60 -66.65 REMARK 500 VAL A 272 -51.72 -121.93 REMARK 500 GLU A 290 49.78 -69.83 REMARK 500 ASN A 370 72.87 -175.13 REMARK 500 ASP B 49 64.48 -67.88 REMARK 500 GLU B 121 -82.62 -113.79 REMARK 500 ASP B 181 44.81 -145.41 REMARK 500 ASP B 200 90.62 59.87 REMARK 500 CYS B 218 149.79 69.52 REMARK 500 CYS B 218 150.88 67.73 REMARK 500 THR B 289 -153.80 -102.01 REMARK 500 GLU B 290 34.84 -149.62 REMARK 500 ASN B 370 71.02 -166.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1JX A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1JX B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4J1R RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH DIFFERENT INHIBITORS REMARK 900 RELATED ID: NYSGRC-030813 RELATED DB: TARGETTRACK DBREF 4J71 A 1 420 UNP P49841 GSK3B_HUMAN 1 420 DBREF 4J71 B 1 420 UNP P49841 GSK3B_HUMAN 1 420 SEQADV 4J71 GLY A -3 UNP P49841 EXPRESSION TAG SEQADV 4J71 SER A -2 UNP P49841 EXPRESSION TAG SEQADV 4J71 PRO A -1 UNP P49841 EXPRESSION TAG SEQADV 4J71 GLY A 0 UNP P49841 EXPRESSION TAG SEQADV 4J71 GLY B -3 UNP P49841 EXPRESSION TAG SEQADV 4J71 SER B -2 UNP P49841 EXPRESSION TAG SEQADV 4J71 PRO B -1 UNP P49841 EXPRESSION TAG SEQADV 4J71 GLY B 0 UNP P49841 EXPRESSION TAG SEQRES 1 A 424 GLY SER PRO GLY MET SER GLY ARG PRO ARG THR THR SER SEQRES 2 A 424 PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SER ALA SEQRES 3 A 424 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 4 A 424 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 5 A 424 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 6 A 424 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 7 A 424 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 8 A 424 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 9 A 424 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 10 A 424 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 11 A 424 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 12 A 424 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 13 A 424 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 14 A 424 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 15 A 424 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 16 A 424 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 17 A 424 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER PTR ILE SEQRES 18 A 424 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 19 A 424 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 20 A 424 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 21 A 424 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 22 A 424 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 23 A 424 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 24 A 424 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 25 A 424 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 26 A 424 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 27 A 424 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 28 A 424 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 29 A 424 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 30 A 424 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 31 A 424 ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SER ASP SEQRES 32 A 424 ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN ALA ALA SEQRES 33 A 424 SER ALA SER ALA SER ASN SER THR SEQRES 1 B 424 GLY SER PRO GLY MET SER GLY ARG PRO ARG THR THR SER SEQRES 2 B 424 PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SER ALA SEQRES 3 B 424 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 4 B 424 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 5 B 424 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 6 B 424 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 7 B 424 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 8 B 424 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 9 B 424 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 10 B 424 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 11 B 424 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 12 B 424 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 13 B 424 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 14 B 424 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 15 B 424 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 16 B 424 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 17 B 424 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER PTR ILE SEQRES 18 B 424 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 19 B 424 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 20 B 424 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 21 B 424 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 22 B 424 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 23 B 424 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 24 B 424 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 25 B 424 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 26 B 424 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 27 B 424 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 28 B 424 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 29 B 424 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 30 B 424 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 31 B 424 ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SER ASP SEQRES 32 B 424 ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN ALA ALA SEQRES 33 B 424 SER ALA SER ALA SER ASN SER THR MODRES 4J71 PTR A 216 TYR O-PHOSPHOTYROSINE MODRES 4J71 PTR B 216 TYR O-PHOSPHOTYROSINE HET PTR A 216 16 HET PTR B 216 16 HET 1JX A 501 12 HET SO4 A 502 5 HET SO4 A 503 5 HET CL A 504 1 HET 1JX B 501 12 HET SO4 B 502 5 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1JX (2R)-2-METHYL-1,4-DIHYDROPYRIDO[2,3-B]PYRAZIN-3(2H)-ONE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 1JX 2(C8 H9 N3 O) FORMUL 4 SO4 3(O4 S 2-) FORMUL 6 CL CL 1- FORMUL 9 HOH *207(H2 O) HELIX 1 1 ASN A 95 LEU A 104 1 10 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 SER A 219 ARG A 223 5 5 HELIX 6 6 ALA A 224 PHE A 229 1 6 HELIX 7 7 SER A 237 GLY A 253 1 17 HELIX 8 8 VAL A 263 GLY A 274 1 12 HELIX 9 9 THR A 277 MET A 284 1 8 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 ARG A 319 1 10 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 HIS A 337 1 8 HELIX 14 14 SER A 338 ASP A 345 5 8 HELIX 15 15 THR A 363 SER A 368 1 6 HELIX 16 16 ASN A 370 PRO A 372 5 3 HELIX 17 17 LEU A 373 ILE A 378 1 6 HELIX 18 18 PRO A 379 ARG A 383 5 5 HELIX 19 19 ASN B 95 LEU B 104 1 10 HELIX 20 20 VAL B 139 ALA B 149 1 11 HELIX 21 21 PRO B 154 SER B 174 1 21 HELIX 22 22 LYS B 183 GLN B 185 5 3 HELIX 23 23 SER B 219 ARG B 223 5 5 HELIX 24 24 ALA B 224 PHE B 229 1 6 HELIX 25 25 SER B 236 GLY B 253 1 18 HELIX 26 26 VAL B 263 GLY B 274 1 12 HELIX 27 27 THR B 277 ASN B 285 1 9 HELIX 28 28 PRO B 300 PHE B 305 1 6 HELIX 29 29 PRO B 310 LEU B 321 1 12 HELIX 30 30 THR B 324 ARG B 328 5 5 HELIX 31 31 THR B 330 ALA B 336 1 7 HELIX 32 32 HIS B 337 PHE B 339 5 3 HELIX 33 33 PHE B 340 ASP B 345 1 6 HELIX 34 34 ASN B 370 PRO B 372 5 3 HELIX 35 35 LEU B 373 ILE B 378 1 6 HELIX 36 36 PRO B 379 ARG B 383 5 5 SHEET 1 A 7 VAL A 37 PRO A 44 0 SHEET 2 A 7 GLN A 52 GLY A 65 -1 O TYR A 56 N THR A 38 SHEET 3 A 7 GLY A 68 LEU A 75 -1 O VAL A 70 N ILE A 62 SHEET 4 A 7 LEU A 81 GLN A 89 -1 O LYS A 86 N VAL A 69 SHEET 5 A 7 VAL A 126 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 A 7 LEU A 112 SER A 119 -1 N PHE A 116 O ASN A 129 SHEET 7 A 7 VAL A 37 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 B 3 GLU A 137 THR A 138 0 SHEET 2 B 3 LEU A 187 ASP A 190 -1 O LEU A 189 N GLU A 137 SHEET 3 B 3 VAL A 195 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 C 2 ILE A 177 CYS A 178 0 SHEET 2 C 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 D 7 VAL B 37 PRO B 44 0 SHEET 2 D 7 GLN B 52 GLY B 65 -1 O VAL B 54 N VAL B 40 SHEET 3 D 7 GLY B 68 LEU B 75 -1 O LYS B 74 N THR B 57 SHEET 4 D 7 LEU B 81 GLN B 89 -1 O LYS B 86 N VAL B 69 SHEET 5 D 7 VAL B 126 ASP B 133 -1 O LEU B 132 N ALA B 83 SHEET 6 D 7 LEU B 112 SER B 118 -1 N PHE B 116 O ASN B 129 SHEET 7 D 7 VAL B 37 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 E 3 GLU B 137 THR B 138 0 SHEET 2 E 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 E 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 F 2 ILE B 177 CYS B 178 0 SHEET 2 F 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 LINK C SER A 215 N PTR A 216 1555 1555 1.33 LINK C PTR A 216 N ILE A 217 1555 1555 1.33 LINK C SER B 215 N PTR B 216 1555 1555 1.33 LINK C PTR B 216 N ILE B 217 1555 1555 1.33 CISPEP 1 GLY B 47 PRO B 48 0 -0.71 SITE 1 AC1 8 VAL A 110 LEU A 132 ASP A 133 TYR A 134 SITE 2 AC1 8 VAL A 135 LEU A 188 HOH A 635 HOH A 656 SITE 1 AC2 5 ARG A 96 ARG A 180 LYS A 205 ASN A 213 SITE 2 AC2 5 VAL A 214 SITE 1 AC3 4 TYR A 146 TYR A 157 TYR A 161 PRO B 51 SITE 1 AC4 4 TYR A 157 PRO A 351 ASN A 352 HOH A 694 SITE 1 AC5 7 VAL B 110 LEU B 132 ASP B 133 TYR B 134 SITE 2 AC5 7 VAL B 135 LEU B 188 HOH B 645 SITE 1 AC6 5 ARG B 96 ARG B 180 LYS B 205 ASN B 213 SITE 2 AC6 5 VAL B 214 CRYST1 63.380 67.116 67.440 99.80 102.94 89.94 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015778 -0.000016 0.003679 0.00000 SCALE2 0.000000 0.014900 0.002640 0.00000 SCALE3 0.000000 0.000000 0.015451 0.00000